论文部分内容阅读
原发性呼吸暂停(AOP)是早产儿常见的临床症状。我院自2001年1月至2005年6月应用纳洛酮治疗AOP 70例,疗效较好,报告如下。对象与方法1．一般资料：本组70例。随机分为观察组和对照组。观察组34例．男23例,女11例；胎龄29～34周,平均(32±1．8)周；出生体重1200～2450g,平均(1580±418)g。对照组36例,男24例,女12例,胎龄29～34周,平均(32±1．7)周；出生体重1250～2450g,平均(1575±422)g。均符合实用新生儿原发性呼吸暂停诊断标准。两组患儿均除外血糖、血钙及其他电解质紊乱．胸部X线除外胸部疾患。两组在性别、胎龄、出生体重、住院期间并发症发生率等均无显著性差异。
Primary apnea (AOP) is a common clinical symptom in preterm infants. Our hospital from January 2001 to June 2005 application of naloxone AOP 70 cases, the effect is better, the report is as follows. Objects and methods 1. General Information: The group of 70 cases. Randomly divided into observation group and control group. Observation group of 34 cases. There were 23 males and 11 females. The gestational age ranged from 29 to 34 weeks, with an average of (32 ± 1.8) weeks. Birth weights ranged from 1,250 to 2,450 g (mean, 1580 ± 418) g. The control group of 36 patients, 24 males and 12 females, gestational age 29 to 34 weeks, an average of (32 ± 1.7) weeks; birth weight 1250 ~ 2450g, an average of (1575 ± 422) g. Are in line with practical diagnostic criteria for neonatal primary apnea. Except for the two groups of children with blood glucose, blood calcium and other electrolyte disorders. Chest X-ray except chest disease. There was no significant difference between the two groups in gender, gestational age, birth weight, incidence of complications during hospitalization.